BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Cochlear Corporation VP Of U.S. Sales Jerry Schloffman Accepts Chief Of Market Development Position At Valencia Technologies

  March 30, 2015

   · 

  2 min read
• Business

  Noven Appoints Scott Briggs As Vice President Of Marketing & Sales

  March 30, 2015

   · 

  1 min read
• Business

  RXi Pharmaceuticals Reports Fourth Quarter And Year End 2014 Financial Results And Recent Corporate Highlights

  March 30, 2015

   · 

  9 min read
• Deals

  Cancer Gene Therapy Biotech MultiVir Files for a $70M IPO

  March 30, 2015

   · 

  1 min read
• Drug Development

  Sigma-Tau Pharmaceuticals Receives Orphan Drug Designation For EZN-2279 For Treatment Of Adenosine Deaminase--Deficient Severe Combined Immunodeficiency Disease

  March 30, 2015

   · 

  4 min read
• FDA

  AstraZeneca PLC Release: BRILINTA Receives FDA Approval For New Administration Option

  March 30, 2015

   · 

  6 min read
• Hospira’s INFLECTRA (Infliximab) Now Available In Canada

  March 30, 2015

   · 

  10 min read
• Pharm Country

  Recombine Announces Launch Of Its CarrierMap Carrier Screening Test Through Sequenom Inc.

  March 30, 2015

   · 

  1 min read
• Covalon Technologies Ltd. Announces Issuance Of Stock Options

  March 30, 2015

   · 

  2 min read
• Biogen Announces European Medicines Agency Validation Of Marketing Authorization Application For SB2, A Biosimilar Candidate For Infliximab

  March 30, 2015

   · 

  4 min read